Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAQSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAQSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XAQEWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XAQEHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
XAQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAQENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XAQNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XAQNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XAQNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAQNCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XAQNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAQNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAQNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XAQNNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XAQORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.2.3.8ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.2.3.8ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.2.3.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.3.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.3.8ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.2.3.8ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.3.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BA.2.3.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.3.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BA.2.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
BA.2.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.2.3.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.3.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.3.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.8NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.3.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.3.8NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.8ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.569ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.569ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.569ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.569ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.569ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.569ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
B.1.569ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.569SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.569SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.569SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.569EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.569EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used